Tongan Zhao

National Institutes of Health — United States

Computer Science · Physical Sciences

15h-index1.6kcitations24works3.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(20), Metabolomics and Mass Spectrometry Studies(6), Microbial Natural Products and Biosynthesis(5), Pharmacogenetics and Drug Metabolism(4), SARS-CoV-2 and COVID-19 Research(3)

Publications24 total

Expanded Tox21 biological assay panel for the prediction of drug-induced liver injury and cardiotoxicity
Environmental Health Perspectives·2025Open Access
Analytical Quality Evaluation of the Tox21 Compound Library
Chemical Research in Toxicology·2024· 8 citedOpen Access
Identification of human pregnane X receptor antagonists utilizing a high-throughput screening platform
Frontiers in Pharmacology·2024· 2 citedOpen Access
Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data
Toxicology and Applied Pharmacology·2022· 39 citedOpen Access
Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability
Bioorganic & Medicinal Chemistry·2022· 57 citedOpen Access
Erratum: CATMoS: Collaborative Acute Toxicity Modeling Suite
Environmental Health Perspectives·2021· 29 citedOpen Access
Erratum: CATMoS: Collaborative Acute Toxicity Modeling Suite
Environmental Health Perspectives·2021· 6 citedOpen Access
CATMoS: Collaborative Acute Toxicity Modeling Suite
Environmental Health Perspectives·2021· 129 citedOpen Access
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Frontiers in Pharmacology·2021· 93 citedOpen Access
Rcurvep: Concentration-Response Data Analysis using Curvep
2021Open Access
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
2020· 30 citedOpen Access
An OpenData portal to share COVID-19 drug repurposing data in real time
2020· 106 citedOpen Access
Novel Consensus Architecture To Improve Performance of Large-Scale Multitask Deep Learning QSAR Models
Journal of Chemical Information and Modeling·2019· 74 citedOpen Access
The NCATS Pharmaceutical Collection: a 10-year update
Drug Discovery Today·2019· 68 cited
The NCATS BioPlanet – An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics
Frontiers in Pharmacology·2019· 301 citedOpen Access
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space
ACS Central Science·2018· 42 citedOpen Access
Canvass: A Crowd-Sourced, Natural Product Screening Library for Exploring Biological Space
2018· 1 citedOpen Access
Canvass: A Crowd-Sourced, Natural Product Screening Library for Exploring Biological Space
2018· 1 citedOpen Access
Canvass: A Crowd-Sourced, Natural Product Screening Library for Exploring Biological Space
2018Open Access
Utilization of Artificial Intelligence to Develop a QSAR Model for Predicting P450 Mediated Metabolic Stability
The FASEB Journal·2018· 1 cited
page 1 of 2Next →

Frequent Co-authors

Anton Simeonov(21), Ruili Huang(17), Menghang Xia(12), Srilatha Sakamuru(12), Paul Shinn(11), Ðắc-Trung Nguyễn(9), Jinghua Zhao(9), Gergely Zahoránszky-Köhalmi(7), Richard T. Eastman(7), Zina Itkin(7), Sam Michael(7), Noel Southall(6), Alexey Zakharov(6), Carleen Klumpp‐Thomas(6), Caitlin Lynch(6), Rajarshi Guha(5), Ajit Jadhav(5), Christopher P. Austin(5), Kyle R. Brimacombe(5), Matthew D. Hall(5)